The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
Blood transfusion is an essential, life-saving treatment required by thousands of patients each day. The blood supply is an irreplaceable, essential public health resource and the blood system infrastructure is critical to our ability to respond to emerging infectious diseases, natural disasters and emergencies. AABB is committed to advancing policy solutions that strengthen the nation’s blood supply and the vein-to-vein infrastructure that supports it.
New Paper Explores the Impact of Climate Change on the Blood Supply
April 22, 2025
AABB Urges Congress to Prioritize NIH Funding
March 19, 2025
February Issue of AABB News Explores Disaster Preparedness
February 11, 2025
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.
©2022 All Rights Reserved. AABB - Association for the Advancement of Blood & Biotherapies
Web Design and Development by Matrix Group International, Inc.